Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
The European Society for Medical Oncology (ESMO) has called on the Member States of the European Union (EU) to adopt stricter limits on air pollution, aiming to prevent lung cancer cases in Europe, following a recently launched proposal to revise the EU’s rules on ambient air quality.
The European Society for Medical Oncology (ESMO) has reached out to key Members of the European Parliament to underline the need for adopting strict EU limits on occupational exposure to asbestos, which is crucial for preventing cancer cases caused by asbestos.
Dr Dario Trapani has been appointed as ESMO’s lead representative in the Healthcare Professionals' Working Party (HCPWP) of the European Medicines Agency (EMA).
The European Society for Medical Oncology (ESMO) responded to the recently launched public consultation on the revision of the EU’s Asbestos at Work Directive and called for the adoption of stricter measures to address the health-related impact of asbestos.
The European Society for Medical Oncology (ESMO) responded to the EUnetHTA 21 public consultation on its draft deliverable D4.4 on ‘Endpoints’.
ESMO President, Solange Peters, was invited by the WHO Regional Director for Europe, Hans Kluge, to provide an ESMO Statement on the resolution of the ‘Roadmap to accelerate the elimination of cervical cancer as a public health problem in the WHO European Region 2022–2030’
ESMO, together with 28 other organisations, endorsed a joint statement supporting the resolution on the ‘Regional digital health action plan for the WHO European Region’
ESMO, together with other organisations, endorsed a joint statement on the ‘Implementation of the Action Plan for the Prevention and Control of Noncommunicable Diseases in the WHO European Region 2016–2025: Progress report’
ESMO, together with other organisations, endorsed a joint statement on the resolution on the ‘WHO European framework for action to achieve the highest attainable standard of health for persons with disabilities 2022–2030’
An ESMO statement was delivered by the ESMO Director of Public Policy, Rosa Giuliani, on the topic of ‘Follow-up to the political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases’ during the World Health Assembly (WHA75), 22-28 May 2022
An ESMO statement was delivered by the ESMO Director of Public Policy, Rosa Giuliani, on the topic of ‘The Public Health Dimension of the World Drug Problem’, during the World Health Assembly (WHA75), 22-28 May 2022.
An ESMO statement was delivered by the ESMO President, Solange Peters, on the topic of Human Resources for Health, during the World Health Assembly (WHA75), 22-28 May 2022.
ESMO delivered an official statement at the Special Session of the World Health Assembly to strengthen pandemic prevention, preparedness and response
The protection of cancer patients through immunisation against COVID-19 is a public health priority
Decide is the Health Decision Hub hosted by the World Health Organisation
ESMO has been granted ‘special consultation status’ with the United Nations Economic and Social Council (ECOSOC).
ESMO President Solange Peters and ESMO officers Paolo G. Casali and Elisabeth De Vries have been invited to speak at the virtual meeting [29 October] marking 25 years of EMA's strong commitment to protect public health with a focus on cancer
ESMO congratulated the United Nations on 75 years of achievements in defence of health as a human right which it celebrated in a virtual High-Level Meeting to Commemorate the 75th Anniversary of the United Nations on 21 September.
An ambitious European Programme of Work (EPW 2020–2025) – “United Action for Better Health in Europe” has just been adopted by WHO Europe at its virtual Regional Committee Meeting (14-15 September 2020)
WHO Guide ‘Selection of Essential Medicines at Country Level: Using the WHO Model List of Essential Medicines to update a national essential medicines list’
Biosimilars have a fascinating story of development, says Rosa Giuliani, and understanding it is crucial for widespread adoption.
The European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO), the world’s two leading organisations for oncology professionals, today issued a joint statement calling upon governments to renew political commitment to improve cancer services and reduce cancer deaths.
At the 71st World Health Assembly (WHA) in Geneva, Switzerland, ESMO, the leading professional organisation for medical oncology, delivered two statements positioning cancer as a priority on the World Health Organisation’s (WHO) global agenda.
Policy recommendations and concrete actions governments can take towards achieving the goals of the landmark World Health Assembly Resolution on ‘Cancer prevention and control within an integrated approach’ adopted unanimously by the 194 WHO Member States in May 2017.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
